Article
Clinical guideline variability in the diagnosis of hereditary hematopoietic malignancy syndromes.
Leukemia & lymphoma - 1 Sept 2023
Hamidi Adam, Roloff Gregory W, Shaw Reid, Acevedo Maria, Smith Shaili, Drazer Michael W
Abstract excerpt
A growing understanding of the complexities of hematopoietic malignancies necessitates the existence of clinical recommendations that are sufficiently comprehensive. Although hereditary hematopoietic malignancies (HHMs) are increasingly recognized for conferring risk of myeloid malignancy, frequently utilized clinical recommendations have never been appraised for the ability to reliably guide HHM evaluation. We...
Topics
Join the communities discussing this publication.